Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Debt / Capital

Amneal Pharmaceuticals Inc Total Debt / Capital Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Debt / Capital from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the last 12 months ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Annual Total Debt / Capital for 2018 was $75m a -78.41% decrease of -59m from 2017
  • Amneal Pharmaceuticals Inc Annual Total Debt / Capital for 2017 was $134m a 12.41% increase of 17m from 2016
  • Amneal Pharmaceuticals Inc Annual Total Debt / Capital for 2016 was $117m a -4.62% decrease of -5m from 2015
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX Total Debt / Capital Data

12/2018$75m
09/2018$76m
06/2018$75m
03/2018$133m
12/2017$134m
09/2017$141m
03/2017$117m
12/2016$117m

Annual AMRX Total Debt / Capital Data

2018$75m
2017$134m
2016$117m
2015$123m